Bristol-Myers Squibb Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 3,153.0 | 2,083.0 | 1,836.0 |
| Net Investing Cash Flow | (202.0) | 206.0 | 1,191.0 |
| Net Financing Cash Flow | (3,213.0) | (3,351.0) | (3,637.0) |
| Net Change in Cash | (217.0) | (1,032.0) | (630.0) |
| Depreciation & Amortization | 892.0 | 927.0 | 929.0 |
| Capital Expenditures | (843.0) | (785.0) | (738.0) |
| Cash Dividends Paid | (2,213.0) | (2,199.0) | (2,186.0) |




